CS250242B2 - Method of 2,2-imino-bis-ethanol's new benzopyran's or benzofuran's derivatives preparation - Google Patents
Method of 2,2-imino-bis-ethanol's new benzopyran's or benzofuran's derivatives preparation Download PDFInfo
- Publication number
- CS250242B2 CS250242B2 CS849320A CS932084A CS250242B2 CS 250242 B2 CS250242 B2 CS 250242B2 CS 849320 A CS849320 A CS 849320A CS 932084 A CS932084 A CS 932084A CS 250242 B2 CS250242 B2 CS 250242B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- parts
- dihydro
- benzopyran
- formula
- methanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55808183A | 1983-12-05 | 1983-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS250242B2 true CS250242B2 (en) | 1987-04-16 |
Family
ID=24228139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS849320A CS250242B2 (en) | 1983-12-05 | 1984-12-04 | Method of 2,2-imino-bis-ethanol's new benzopyran's or benzofuran's derivatives preparation |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0145067B1 (fi) |
| JP (1) | JPS60132977A (fi) |
| KR (1) | KR870000923B1 (fi) |
| AR (1) | AR241414A1 (fi) |
| AT (1) | ATE40361T1 (fi) |
| AU (1) | AU573658B2 (fi) |
| BG (1) | BG43866A3 (fi) |
| CA (1) | CA1337429C (fi) |
| CS (1) | CS250242B2 (fi) |
| CY (1) | CY1609A (fi) |
| DD (1) | DD235453A5 (fi) |
| DE (1) | DE3476388D1 (fi) |
| DK (2) | DK165112C (fi) |
| DZ (1) | DZ712A1 (fi) |
| ES (1) | ES8603870A1 (fi) |
| FI (1) | FI82460C (fi) |
| GR (1) | GR81098B (fi) |
| HK (1) | HK52791A (fi) |
| HU (1) | HU202219B (fi) |
| IE (1) | IE57831B1 (fi) |
| IL (1) | IL73706A (fi) |
| MA (1) | MA20292A1 (fi) |
| NO (2) | NO169839C (fi) |
| NZ (1) | NZ210388A (fi) |
| PH (1) | PH22432A (fi) |
| PL (1) | PL146342B1 (fi) |
| PT (1) | PT79609B (fi) |
| RO (1) | RO91184B (fi) |
| SG (1) | SG47091G (fi) |
| SU (1) | SU1428199A3 (fi) |
| ZA (1) | ZA849445B (fi) |
| ZW (1) | ZW19784A1 (fi) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1337432C (en) * | 1988-03-23 | 1995-10-24 | Raymond M. Xhonneux | Method of lowering the blood pressure |
| JPH02103116U (fi) * | 1989-02-01 | 1990-08-16 | ||
| JPH02218675A (ja) * | 1989-02-21 | 1990-08-31 | Nippon Kayaku Co Ltd | ６―フルオロクロモン―２―カルボン酸及びその製造法 |
| IE68675B1 (en) * | 1990-11-01 | 1996-07-10 | Takeda Chemical Industries Ltd | Aminocoumaran derivatives their production and use |
| TW355683B (en) * | 1994-02-17 | 1999-04-11 | Janssen Pharmaceutica Nv | Composition containing micronized nebivolol |
| DK0707007T3 (da) * | 1994-10-14 | 2002-03-18 | Merck Patent Gmbh | Amino(thio)etherderivater som CNS-aktive midler |
| ID26524A (id) * | 1997-12-19 | 2001-01-11 | Bayer Ag | Turunan-turunan kroman tersubstitusi karboksil bermanfaat sebagai agonis beta-3 adrenoreseptor |
| US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US6713651B1 (en) | 1999-06-07 | 2004-03-30 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US6593497B1 (en) | 1999-06-02 | 2003-07-15 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US6683115B2 (en) | 1999-06-02 | 2004-01-27 | Theravance, Inc. | β2-adrenergic receptor agonists |
| UA73965C2 (en) | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
| UA73981C2 (en) | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
| WO2002087508A2 (en) | 2001-05-02 | 2002-11-07 | Nitromed, Inc. | Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| ATE352302T1 (de) | 2001-07-26 | 2007-02-15 | Merck Patent Gmbh | Verwendung von 2- 5-(4-fluorphenyl)-3- pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| WO2003042160A1 (en) | 2001-11-13 | 2003-05-22 | Theravance, Inc. | Aryl aniline beta-2 adrenergic receptor agonists |
| BRPI0513672A (pt) | 2004-07-30 | 2008-05-13 | Torrent Pharmaceuticals Limita | processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol |
| WO2006016376A1 (en) * | 2004-08-11 | 2006-02-16 | Hetero Drugs Limited | A novel process for preparation of nebivolol intermediates |
| CN100341866C (zh) * | 2004-08-30 | 2007-10-10 | 中国科学院理化技术研究所 | α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法 |
| US20070014733A1 (en) * | 2005-01-31 | 2007-01-18 | O'donnell John P | Hydroxylated nebivolol metabolites |
| EP1850842A1 (de) * | 2005-02-11 | 2007-11-07 | Stada Arzneimittel Ag | Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer |
| AT502220A1 (de) * | 2005-07-19 | 2007-02-15 | Pharmacon Forschung & Beratung | Verfahren zur herstellung von nebivolol |
| EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
| US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
| EP1973895A1 (en) | 2006-01-18 | 2008-10-01 | Hetero Drugs Limited | Process for isolation of desired isomers of nebivolol intermediates |
| ITMI20061889A1 (it) * | 2006-10-03 | 2008-04-04 | Zambon Spa | Processo di preparazione di nebivololo |
| CA2667919C (en) | 2006-11-27 | 2014-10-28 | Zach System S.P.A. | Process for preparing nebivolol |
| EP2124931A4 (en) | 2007-01-22 | 2013-08-28 | Mylan Pharmaceuticals Ulc | PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL OR AN ANALOGUE OF NEBIVOLOL |
| CN101463024B (zh) | 2007-12-21 | 2011-06-08 | 上海现代制药股份有限公司 | 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法 |
| ITMI20080547A1 (it) * | 2008-03-31 | 2009-10-01 | Zach System Spa | Processo di preparazione di nebivololo |
| IT1392067B1 (it) * | 2008-10-31 | 2012-02-09 | Zach System Spa | Processo di preparazione di nebivololo |
| IT1395354B1 (it) * | 2009-07-23 | 2012-09-14 | Zach System Spa | Processo di preparazione di nebivololo |
| DE102010005953A1 (de) | 2010-01-27 | 2011-07-28 | Corden PharmaChem GmbH, 68305 | Verfahren zur Herstellung von Nebivolol |
| IT1397962B1 (it) | 2010-02-11 | 2013-02-04 | Menarini Int Operations Lu Sa | Processo per la preparazione del nebivololo. |
| IT1402974B1 (it) | 2010-11-30 | 2013-09-27 | Menarini Int Operations Lu Sa | Processo per la preparazione del nebivololo. |
| ITRM20110418A1 (it) | 2011-08-02 | 2013-02-03 | Menarini Int Operations Lu Sa | Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo. |
| EP2907810A1 (en) | 2014-02-14 | 2015-08-19 | Corden Pharma International GmbH | A new method for producing nebivolol hydrochloride of high purity |
| PT2907809T (pt) | 2014-02-14 | 2019-01-16 | Corden Pharma Int Gmbh | Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol |
| DE102014107132A1 (de) | 2014-05-20 | 2015-11-26 | Corden Pharma International Gmbh | Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind |
| JP6847095B2 (ja) | 2015-05-19 | 2021-03-24 | チョーチアン オウスン ファーマシューティカル カンパニー リミテッド | ネビボロールの合成方法及びその中間化合物 |
| CN105085499B (zh) * | 2015-08-07 | 2018-09-25 | 上海现代制药海门有限公司 | 盐酸奈必洛尔中间体混合物的结晶分离方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054655A (fi) * | 1964-01-24 | |||
| US4313955A (en) * | 1980-10-14 | 1982-02-02 | Ciba-Geigy Corporation | 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols |
| GB8418472D0 (en) * | 1984-07-19 | 1984-08-22 | Beecham Group Plc | Compounds |
-
1984
- 1984-11-19 CA CA000468108A patent/CA1337429C/en not_active Expired - Fee Related
- 1984-11-21 PL PL1984250524A patent/PL146342B1/pl unknown
- 1984-11-22 DE DE8484201693T patent/DE3476388D1/de not_active Expired
- 1984-11-22 AT AT84201693T patent/ATE40361T1/de not_active IP Right Cessation
- 1984-11-22 EP EP84201693A patent/EP0145067B1/en not_active Expired
- 1984-11-26 KR KR1019840007404A patent/KR870000923B1/ko not_active IP Right Cessation
- 1984-11-29 NZ NZ210388A patent/NZ210388A/en unknown
- 1984-11-29 GR GR81098A patent/GR81098B/el unknown
- 1984-11-30 JP JP59252038A patent/JPS60132977A/ja active Granted
- 1984-12-02 DZ DZ847346A patent/DZ712A1/fr active
- 1984-12-03 RO RO116496A patent/RO91184B/ro unknown
- 1984-12-03 AR AR84298819A patent/AR241414A1/es active
- 1984-12-03 IL IL73706A patent/IL73706A/xx not_active IP Right Cessation
- 1984-12-03 DD DD84270216A patent/DD235453A5/de not_active IP Right Cessation
- 1984-12-04 NO NO844845A patent/NO169839C/no not_active IP Right Cessation
- 1984-12-04 ZA ZA849445A patent/ZA849445B/xx unknown
- 1984-12-04 ES ES538256A patent/ES8603870A1/es not_active Expired
- 1984-12-04 IE IE3103/84A patent/IE57831B1/en not_active IP Right Cessation
- 1984-12-04 SU SU843826501A patent/SU1428199A3/ru active
- 1984-12-04 BG BG067765A patent/BG43866A3/xx unknown
- 1984-12-04 DK DK577084A patent/DK165112C/da not_active IP Right Cessation
- 1984-12-04 ZW ZW197/84A patent/ZW19784A1/xx unknown
- 1984-12-04 MA MA20516A patent/MA20292A1/fr unknown
- 1984-12-04 CS CS849320A patent/CS250242B2/cs unknown
- 1984-12-04 PT PT79609A patent/PT79609B/pt unknown
- 1984-12-04 PH PH31525A patent/PH22432A/en unknown
- 1984-12-04 FI FI844777A patent/FI82460C/fi active IP Right Grant
- 1984-12-04 HU HU844482A patent/HU202219B/hu unknown
- 1984-12-05 AU AU36326/84A patent/AU573658B2/en not_active Expired
-
1991
- 1991-06-18 SG SG47091A patent/SG47091G/en unknown
- 1991-07-11 HK HK527/91A patent/HK52791A/xx not_active IP Right Cessation
-
1992
- 1992-01-31 DK DK011892A patent/DK165321C/da not_active IP Right Cessation
- 1992-04-03 CY CY1609A patent/CY1609A/xx unknown
-
2004
- 2004-11-26 NO NO2004007C patent/NO2004007I2/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS250242B2 (en) | Method of 2,2-imino-bis-ethanol's new benzopyran's or benzofuran's derivatives preparation | |
| US4654362A (en) | Derivatives of 2,2'-iminobisethanol | |
| JP3659969B2 (ja) | 血管収縮性の置換アリールオキシアルキルジアミン類 | |
| US4251537A (en) | Hypotensive 3,4-dihydro-2,2-dimethyl-4-amino-2H-benzo[b]pyran-3-ols | |
| CZ282092B6 (cs) | /(Benzodioxan, benzofuran nebo benzopyran)alkylamino/alkylsubstituované guanidiny, způsob jejich výroby, meziprodukty pro jejich výrobu, farmaceutické přípravky na jejich bázi a způsob výroby těchto farmaceutických přípravků | |
| CZ37496A3 (en) | Derivatives of dihydrobenzopyran per se and for the use in medicine, process and intermediates for their preparation, pharmaceutical compositions based thereon and process of their preparation | |
| FI90979B (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| US5130322A (en) | Chroman derivatives | |
| DK167440B1 (da) | Alkylsubstituerede n-benzopyranyllactamer, fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse forbindelser | |
| HUT58323A (en) | Process for producing new chromane derivatives and pharmaceutical compositions containing them | |
| KR0150780B1 (ko) | 크로만 유도체 | |
| CZ299199A3 (cs) | Oxazolidinony jako 5-HT2A antagonisty | |
| HU207510B (en) | Process for producing cumarine derivatives and pharmaceutical compositions containing cerebral vasodilatators | |
| FR2623808A1 (fr) | Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| AU645373B2 (en) | Chroman derivatives | |
| EP0005610B1 (en) | 1-(heterocyclylalkyl)-1,3-dihydro-2h-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers | |
| US5990123A (en) | Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines | |
| US5691344A (en) | Vasoconstrictive substituted dihydropyranopyridines | |
| US5703115A (en) | (benzodioxan, benzofuran or benzopyran) alkylamino! alkyl substituted guanidines | |
| EP0378159A1 (en) | 7-Aryl- and heteroaryl ethers of desacetylforskolin, a process for their preparation and their use as medicaments | |
| JP2003531198A (ja) | ベンゾキサジン及びベンゾチアジン誘導体並びにそれらの薬剤の利用 | |
| JPH11180972A (ja) | ジヒドロナフトピラン誘導体 | |
| ZA200407482B (en) | Fused tricyclic heterocycles useful for treating hyperproliferative disorders. | |
| JPH06227976A (ja) | エステル誘導体、その製造方法およびロイコトリエン媒介疾患または医学的症状に使用するための製薬学的組成物 |